VEXAS syndrome
VEXAS syndrome
Explore linked clinical trials. Standard reference: MONDO:002677712 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS Followed by Open-Label Extension (OLE) Period | Arthralgia, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, VEXAS syndrome, arthritic joint disease, arthropathy, musculoskeletal system disorder | Recruiting | Phase 2 | 2026-09-29 | NCT07748624 | |
| A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS) | Hemic and Lymphatic Diseases, Neoplasms by Site, VEXAS syndrome, bone marrow disorder, hematologic disorder, hematopoietic and lymphoid system neoplasm, myelodysplastic syndrome, neoplasm | Active, not recruiting | Phase 2 | 2026-09-15 | NCT06782373 | |
| Momelotinib in VEXAS Syndrome | Hemic and Lymphatic Diseases, VEXAS syndrome, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Recruiting | Phase 2 | 2026-08-10 | NCT07098936 | |
| Clinical Phenotype and Prevalence of VEXAS Syndrome in Internal Medicine | VEXAS syndrome | Not yet recruiting | Not stated | 2026-07-16 | NCT07708688 | |
| Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome | VEXAS syndrome | Recruiting | Phase 1 | 2026-07-15 | NCT06538181 | |
| Autoimmune and Autoinflammatory Genetics Study | Skin and Connective Tissue Diseases, VEXAS syndrome, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder | Recruiting | Not stated | 2026-07-08 | NCT06004349 | |
| A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome | VEXAS syndrome | Not yet recruiting | Phase 2 / Phase 3 | 2026-06-01 | NCT07569081 | |
| Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection | VEXAS syndrome | Recruiting | Not stated | 2026-05-15 | NCT06377462 | |
| Clonal Hematopoiesis of Immunological Significance | Blood Protein Disorders, Hemic and Lymphatic Diseases, Hypergammaglobulinemia, Inflammation, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, VEXAS syndrome, autoimmune disease, bone marrow disorder, clonal hematopoiesis of indeterminate potential, hematologic disorder, immune system disorder, immunoproliferative disorder, juvenile myelomonocytic leukemia, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, monoclonal gammopathy of uncertain significance, myelodysplastic syndrome, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm | Not yet recruiting | Not stated | 2026-03-23 | NCT05969821 | |
| Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study | Bone Marrow Failure Disorders, Hemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, VEXAS syndrome, anemia, aplastic anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndrome | Enrolling by invitation | Not stated | 2025-12-22 | NCT07102849 | |
| HRQoL and Financial Toxicity in Patients With VEXAS Syndrome | VEXAS syndrome | Recruiting | Not stated | 2025-07-15 | NCT06657846 | |
| AutoInflammatory Disease Alliance Registry (AIDA) | Behcet disease, Castleman disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Marshall syndrome, PFAPA syndrome, Schnitzler syndrome, Skin and Connective Tissue Diseases, Spondylarthritis, Stomatognathic Diseases, VEXAS syndrome, anterior uveitis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, cardiovascular disorder, connective tissue disorder, eye disorder, hereditary disease, hereditary periodic fever syndrome, hereditary skin disorder, immune system disorder, immunoproliferative disorder, juvenile idiopathic arthritis, lymphatic system disorder, lymphoproliferative syndrome, monoclonal gammopathy, monoclonal gammopathy of uncertain significance, mouth disorder, musculoskeletal system disorder, panuveitis, rheumatic disorder, scleral disorder, scleritis, skin disorder, skin vascular disease, spondylitis, systemic-onset juvenile idiopathic arthritis, uveal disorder, uveitis, vascular disorder, vasculitis, vertebral column disorder | Recruiting | Not stated | 2025-07-10 | NCT05200715 |